Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
about
Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and RecommendationsCost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK.Cost-effectiveness analysis of umeclidinium/vilanterol for the management of patients with moderate to very severe COPD using an economic model.Cost-effectiveness of umeclidinium compared with tiotropium and glycopyrronium as monotherapy for chronic obstructive pulmonary disease: a UK perspective.
P2860
Cost-effectiveness of tiotropium versus usual care and glycopyrronium in the treatment of chronic obstructive pulmonary disease in Sweden
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cost-effectiveness of tiotropi ...... ve pulmonary disease in Sweden
@ast
Cost-effectiveness of tiotropi ...... ve pulmonary disease in Sweden
@en
type
label
Cost-effectiveness of tiotropi ...... ve pulmonary disease in Sweden
@ast
Cost-effectiveness of tiotropi ...... ve pulmonary disease in Sweden
@en
prefLabel
Cost-effectiveness of tiotropi ...... ve pulmonary disease in Sweden
@ast
Cost-effectiveness of tiotropi ...... ve pulmonary disease in Sweden
@en
P2093
P2860
P1476
Cost-effectiveness of tiotropi ...... ve pulmonary disease in Sweden
@en
P2093
Faraz Afzal
Fredrik Borgström
Oskar Eklund
P2860
P2888
P356
10.1186/S12962-015-0040-1
P577
2015-08-19T00:00:00Z
P5875
P6179
1039157177